+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Insulin Resistance"

From
Insulin Resistance - Epidemiology Forecast to 2032 - Product Thumbnail Image

Insulin Resistance - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Diabetes Care Market - Forecasts from 2018 to 2023 - Product Thumbnail Image

Diabetes Care Market - Forecasts from 2018 to 2023

  • Report
  • April 2018
  • 112 Pages
  • Global
From
Pediatric Type II Diabetes - Product Thumbnail Image

Pediatric Type II Diabetes

  • Book
  • December 2018
Loading Indicator

Insulin resistance is a condition in which the body's cells do not respond normally to the hormone insulin. This can lead to high blood sugar levels, which can cause a range of health problems. Endocrinology is the medical specialty that deals with the diagnosis and treatment of disorders related to hormones and the endocrine system. Insulin resistance is a major concern in endocrinology, as it can lead to type 2 diabetes, obesity, and other metabolic disorders. Treatment for insulin resistance typically involves lifestyle changes such as diet and exercise, as well as medications. Companies in the insulin resistance market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and Boehringer Ingelheim. Show Less Read more